Add Formweb to your mobile device
Search results for:
cefTAZidime
cefTAZidime
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POWDER FOR INJECTION, INJECTABLE | 1 g, 2 g |
Last updated: Apr. 21, 2025
cefTAZidime
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POWDER FOR INJECTION, INJECTABLE | 1 g, 2 g |
Antibiotic
Usual Dose
Renal Adjustment
HD
CAPD
CRRT: Consult Pharmacy Clinical Specialist for Dose Determination
Ceftazidime
Severe infections:
Febrile neutropenia, critically ill, meningitis, pseudomonas,CF, endocarditis, PNA
1 g q8h
Severe infections:
2 g IV q8h
CrCl 31-50: 1 g q12h
CrCl 16-30: 1 g q24h
CrCl <10: 500mg q24h
Severe infections:
CrCl 31-50: 2 g q12h
CrCl 16-30: 2 g q24h
CrCl <16: 1 g q24h
500 mg q24h
Severe infections:
1 g q24h
(Dose after HD on HD days)
1 g q24h
2 g q12h